showed a trendp = 0.067
Median colloid size was significantly smaller in naked mole-rats compared to mice and showed a trend towards smaller colloids compared to Ansell’s mole-rats ( p = 0.067).
Median colloid size was significantly smaller in naked mole-rats compared to mice and showed a trend towards smaller colloids compared to Ansell’s mole-rats ( p = 0.067).
However, when comparing baseline to Simeox ® treatment, although the treatment effect was not significant for the R 5 Hz, the treatment effect showed a trend with a p -value = 0.067.
Regarding the stimulation frequencies, the moderator analysis with absolute effect sizes supported the notion that high-frequency TMS would significantly influence RT ( g = 0.21, 95% CI: 0.03–0.38, p = 0.019), while low-frequency TMS showed a trend toward significantly affecting ACC ( g = 0.16, 95% CI: −0.01–0.34, p = 0.067).
sc IFN β‐1a‐ versus placebo‐treated patients Patients treated with sc IFN β‐1a had a lower mean (±SD) number of new/enlarging lesions ( n = 273; 6.9 ± 10) compared with placebo‐treated patients ( n = 134; 10.9 ± 16, p < 0.01), while the lesion volume increase of new/enlarging lesions showed a trend towards reduction in treated patients (0.47 ± 0.99 vs. 0.88 ± 1.48 cm 3 , p = 0.067), after adjusting for age, sex, center, and conversion.
The chemotherapy group showed a trend towards a lower GMT (84.1; 95% CI, 40.0–216.0) compared to the control group (195.0; 95% CI, 40.0–539.9) ( P = 0.067) at 3–6 months post-vaccination.
The three factors of The Monash Dog–Owner Relationship Scale (MDORS) were reflected in the dogs’ heart rate variability and behaviors: the Emotional Closeness factor was related to increased HRV ( p = 0.009), suggesting this aspect is associated with the secure base effect, and the Shared Activities factor showed a trend toward lower HRV ( p = 0.067) along with more owner-directed behaviors reflecting attachment related arousal.
In addition, in the HP group, the BKB intervention showed a trend (− 6%, P = 0.067) towards lowering the postprandial b-glucose response (AUC 0–150 min), see Table 4 and Fig. 2 .
IL-1β levels showed a trend for correlation with MOM feed (p-value=0.067) ( Figure 3C ), while it did not associate with GA ( Figure 3D ).
The intention (OR 1.9; 95% CI 0.7–5.3; p = 0.192) scores showed a trend for higher chances of reaching the VO 2peak reference values, whereas perceived behavior control (OR 0.4; 95% CI 0.2–1.0; p = 0.067) and subjective norms (OR 0.8; 95% CI 0.4–1.5; p = 0.491) scores showed the opposite tendency.
For males, the expected turn taking level showed a trend, with randomised values of the warm treatment showing slightly higher values (Treatment: F 1,33 = 3.59, P = 0.067).
Npas4 showed a trend for main effect of treatment ( F drinking = 4.07, p = 0.067).
In the CLEAR study, patients with CPS < 1 showed a trend towards a longer PFS in the sunitinib arm ( p = 0.067) [ 12 ].
The non-SC subtype was an independent prognostic factor for both worse PFS (adjusted-HR = 1.62; p = 0.016) and OS (adjusted-HR = 1.64; p = 0.015), whereas a Ki-67 index of ≥55% (significantly enriched in the SC subgroup; Table 1 ) was an independent prognostic factor for worse PFS (adjusted-HR = 1.80; p = 0.028) and showed a trend towards worse OS (adjusted-HR = 1.63; p = 0.067).
Although not statistically significant, HXN-treated mice showed a trend toward a lower AUC ( Figure 2—figure supplement 1B , p=0.067).
Surgical Efficiency As for surgical duration the 3D heads-up group showed a trend toward shorter surgical times (median: 50.0 min) compared to the conventional group (median: 60.0 min), approaching statistical significance ( p = 0.067).
The HR of HFmrEF patients without AR was not different to respective HFpEF patients (HR: 0.2 [95% CI: 0.03–1.52], P = 0.874), and presence of AR in HFmrEF patients showed a trend towards increased ACM in the HFmrEF group (HR: 7.11 [95% CI: 0.87–57.79], P = 0.067) ( Figure 1 ).
In summary, the F ‐test for this linear regression was not significant but showed a trend ( F [1,20] = 3.76, p = .067).
Patients harbouring at least one TA ‐allele had a lower MELD (9 (8‐12) vs 10 (8‐13) points; P = .003) and showed a trend towards lower HVPG (16 ± 6 vs 17 ± 7 mmHg; P = .067).
Therefore, utilizing UDS as a preliminary screening tool for early TA detection in children with unexplained fevers is a promising strategy, potentially reducing the interval between disease onset and diagnosis, which in our study showed a trend toward association with refractory and relapsing TA ( p = 0.067), although this did not reach statistical significance.
Hap-A1 also showed a trend of association with low CD4 count in the NT mothers ( P =0.067).
Furthermore, Pb-fed birds showed a trend towards increased villus surface area ( VSA ) ( P = 0.067).
The analysis of MFS in the 345 chemotherapy‐untreated cases showed a trend ( P = 0.067, log‐rank test) for longer MFS in the ‘PARP1‐low’ class (71% 5‐year MFS, 95% CI: 64–78) than in the ‘PARP1‐high’ class (60% 5‐year MFS, 95% CI: 50–73).
The group receiving cognitive therapy also had a significantly narrower range of sleep duration ( p = 0.004), and showed a trend level significance for longer bad night sleep duration ( p = 0.067).
Comparison of the PFS between the T790M-loss group and the T790M-persistent group showed a trend toward worse PFS in the T790M-loss group (4.4 vs. 7.7 months, P = 0.067) ( Fig 5 ).
Amongst them, recipient gender and serum alkaline phosphatase (SALP) enzyme in LTr showed a trend ( P = 0.067 and P = 0.078, respectively) to a worse post-transplant primary study point, whereas in KTr, recipient gender in conjunction with SALP, serum creatinine levels and dose of MMF, were significantly observed as independent risk factor of post-transplant OI episodes ( P = 0.046, P = 0.016, P = 0.014 and P = 0.035, respectively).